These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7011582)

  • 41. Ascorbic acid antagonizes the inhibitory effect of acute ethanol on nitrite levels in the striatum of freely moving mice.
    Yan PG; Wu CF; Huang M; Liu W; Yang JY
    Neurosci Lett; 2003 Dec; 352(3):183-6. PubMed ID: 14625015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of mutagens from pyrolysates of tryptophan and glutamic acid by nitrite in acidic solution.
    Tsuda M; Takahashi Y; Nagao M; Hirayama T; Sugimura T
    Mutat Res; 1980 Aug; 78(4):331-9. PubMed ID: 7003371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of the nitrosation of aminopyrine to give dimethylnitrosamine.
    Mirvish SS; Gold B; Eagen M; Arnold S
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 82(4):259-68. PubMed ID: 4280344
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative study on organ-specificity of tumorigenicity, mutagenicity and cell proliferative activity induced by dimethylnitrosamine in Big Blue mice.
    Nishikawa A; Furukawa F; Kasahara K; Lee IS; Suzuki T; Hayashi M; Sofuni T; Takahashi M
    Cancer Lett; 1997 Aug; 117(2):143-7. PubMed ID: 9377541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitrite-induced volatile mutagens from normal human feces.
    Rao BG; MacDonald IA; Hutchison DM
    Cancer; 1981 Mar; 47(5):889-94. PubMed ID: 7226041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental models for the biological detection of N-nitroso compounds formed from amines and nitrite.
    Baumeister M
    Toxicol Lett; 1982 Aug; 12(4):281-8. PubMed ID: 6753243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential mutagenicity of reaction products of various pyrazolones with nitrite.
    Arisawa M; Fujiu M; Suhara Y; Maruyama HB
    Mutat Res; 1978 Jul; 57(3):287-96. PubMed ID: 27721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of amine-nitrite hepatotoxicity by alpha-tocopherol.
    Kamm JJ; Dashman T; Newmark H; Mergens WJ
    Toxicol Appl Pharmacol; 1977 Sep; 41(3):575-83. PubMed ID: 918988
    [No Abstract]   [Full Text] [Related]  

  • 49. Letter: Ascorbic acid and nitrosamine.
    Mirvish SS; Shrubik P
    Nature; 1974 Aug; 250(5468):684. PubMed ID: 4852702
    [No Abstract]   [Full Text] [Related]  

  • 50. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cytochrome p-448 and p-450 inducers on microsomal dimethylnitrosamine demethylase activity and the capacity of isolated microsomes to activate dimethylnitrosamine to a mutagen.
    Guttenplan JB; Hutterer F; Garro AJ
    Mutat Res; 1976 Jun; 35(3):415-22. PubMed ID: 778603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutagenicity of dimethylnitrosamine to mammalian cells as determined by the use of mouse liver microsomes.
    Umeda M; Saito M
    Mutat Res; 1975 Nov; 30(2):249-54. PubMed ID: 1207708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting metabolism and mutagenicity of dimethylnitrosamine and diethylnitrosamine.
    Frantz CN; Malling HV
    Cancer Res; 1975 Sep; 35(9):2307-14. PubMed ID: 1097107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined ascorbic acid and sodium nitrite treatment induces oxidative DNA damage-associated mutagenicity in vitro, but lacks initiation activity in rat forestomach epithelium.
    Kuroiwa Y; Yamada M; Matsui K; Okamura T; Ishii Y; Masumura K; Tasaki M; Umemura T; Mitsumori K; Nohmi T; Hirose M; Nishikawa A
    Toxicol Sci; 2008 Aug; 104(2):274-82. PubMed ID: 18434339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of nitrosamine formation in vitro by sorbic acid.
    Tanaka K; Chung KC; Hayatsu H; Kada T
    Food Cosmet Toxicol; 1978 Jun; 16(3):209-15. PubMed ID: 99355
    [No Abstract]   [Full Text] [Related]  

  • 56. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
    Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM
    J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ester-mediated nitrosamine formation from nitrite and secondary or tertiary amines.
    Loeppky RN; Tomasik W; Millard TG
    IARC Sci Publ; 1984; (57):353-63. PubMed ID: 6533026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutagenicity of amine drugs and their products of nitrosation.
    Andrews AW; Lijinsky W; Snyder SW
    Mutat Res; 1984 Feb; 135(2):105-8. PubMed ID: 6363913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ; Mitchell VD
    Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of some inhibitors on the nitrosation of drugs in human gastric juice.
    Ziebarth D; Scheunig G
    IARC Sci Publ (1971); 1976; (14):279-90. PubMed ID: 12090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.